tirzepatide lawsuit update today FDA says the weight-loss drug shortage is over FDA says this weight loss

This resource hub features our latest webinars and articles covering FDA guidance, reimbursement strategies, payer trends, state board enforcement, litigation risks, and compliance strategies to help you stay informed and compliant amid rapidly evolving developments in the GLP-1 space

Microdosing means using a much smaller dose of a GLP-1 medication than whats typically prescribed for diabetes or weight loss often a fraction of the standard starting dose

Kos K, Baker AR, Jernas M, Harte AL, Clapham JC, OHare JP, Carlsson L, Kumar S, McTernan PG

Patent protections for semaglutide (Ozempic/Wegovy) expire in 2026 in Canada, India, Brazil and China, opening the door for lower-cost biosimilar generic versions

Some patients find that taking their injection at bedtime rather than morning minimizes daytime nausea awareness